AKT is a therapeutic target in myeloproliferative neoplasms

I. Khan, Z. Huang, Q. Wen, M. J. Stankiewicz, L. Gilles, B. Goldenson, R. Schultz, L. Diebold, S. Gurbuxani, C. M. Finke, T. L. Lasho, P. Koppikar, A. Pardanani, B. Stein, J. K. Altman, R. L. Levine, A. Tefferi, J. D. Crispino

Research output: Contribution to journalArticlepeer-review

44 Scopus citations

Fingerprint Dive into the research topics of 'AKT is a therapeutic target in myeloproliferative neoplasms'. Together they form a unique fingerprint.

Medicine & Life Sciences